Evofem Biosciences, Inc. ·
EVFM 8-K 2026-09-23
Evofem Biosciences, Inc. (EVFM) 8-K dated 2026-09-23 — accession 0001493152-26-043919.
Evofem Biosciences, Inc. (EVFM) is a biotechnology company listed on US.
Evofem Biosciences, Inc. filed a 8-K on 2026-09-23. Accession 0001493152-26-043919.
This 8-K covers: Material agreement (Item 1.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported EVFM revenue for 2025-12-31 was $20.2M. Net income was $391.0K. Revenue was up 4.2% from 2024-12-31 to 2025-12-31. EVFM currently screens at market cap $927.7K.
Not investment advice. The EVFM SEC hub lists recent forms. The stock page is the research view.